Measured Risk Portfolios’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Sell
196
-27
-12% -$27.6K 0.21% 59
2026
Q1
$205K Hold
223
– – 0.22% 64
2025
Q4
$240K Buy
+223
New +$213K 0.24% 60
2025
Q1
– Sell
-224
Closed -$173K – 199
2024
Q4
$173K Buy
+224
New +$185K 0.18% 64

Other funds holding LLY

Measured Risk Portfolios's LLY Position: Q2 2026 in Review

Measured Risk Portfolios reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $27.6K and leaving 196 shares worth $235K. The position accounts for 0.21% of the portfolio, ranked #59.

Measured Risk Portfolios first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $240K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Measured Risk Portfolios held 196 shares of Eli Lilly worth $235K as of Q2 2026.
  • Measured Risk Portfolios sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
  • Eli Lilly made up 0.21% of Measured Risk Portfolios's portfolio in Q2 2026, its #59 holding.
  • Measured Risk Portfolios first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • Measured Risk Portfolios's Eli Lilly position peaked at $240K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Measured Risk Portfolios's 13F filing for Q2 2026, filed 12 Aug 2026.